Roberto Manzini
Zurich, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Corrigendum to Protein tyrosine phosphatase nonreceptor type 2 controls colorectal cancer development.
Journal: The Journal of clinical investigation
Published: April 01, 2026
Blood-borne immune cells carry low biomass DNA remnants of microbes in patients with colorectal cancer or inflammatory bowel disease.
Journal: Gut microbes
Published: July 21, 2025
Impact of Nanoplastic Particles on Macrophage Inflammation and Intestinal Health in a Mouse Model of Inflammatory Bowel Disease.
Journal: Nanomaterials (Basel, Switzerland)
Published: July 12, 2024
Titanium Dioxide Presents a Different Profile in Dextran Sodium Sulphate-Induced Experimental Colitis in Mice Lacking the IBD Risk Gene Ptpn2 in Myeloid Cells.
Journal: International journal of molecular sciences
Published: November 17, 2020
Energy Drink Administration Ameliorates Intestinal Epithelial Barrier Defects and Reduces Acute DSS Colitis.
Journal: Inflammatory bowel diseases
Published: October 20, 2020
Combination of Vedolizumab With Tacrolimus Is More Efficient Than Vedolizumab Alone in the Treatment of Experimental Colitis.
Journal: Inflammatory bowel diseases
Published: October 13, 2020
Protein tyrosine phosphatase nonreceptor type 2 controls colorectal cancer development.
Journal: The Journal of clinical investigation
Published: May 14, 2020
Solute carrier family 12 member 2 as a proteomic and histological biomarker of dysplasia and neoplasia in ulcerative colitis.
Journal: Journal of Crohn's & colitis
Published: April 23, 2020
Deletion of Protein Tyrosine Phosphatase Nonreceptor Type 2 in Intestinal Epithelial Cells Results in Upregulation of the Related Phosphatase Protein Tyrosine Phosphatase Nonreceptor Type 23.
Journal: Inflammatory intestinal diseases
Published: September 20, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026